Salivary anti-PGL IgM and IgA titers and serum antibody IgG titers and avidities in leprosy patients and their correlation with time of infection and antigen exposure

Brazilian Journal of Infectious Diseases

Volumn 11, Issue 2, 2007, Pages 215-219

  Nagao Dias, Aparecida Tiemi ^a   Almeida, Thereza Lúcia P ^a   Oliveira, Maria de Fátima ^a   Santos, Rivanda C ^a   Lima, Ana Laura P ^a   Brasil, Márcia ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Anti PGL 1; Avidity; Leprosy; Salivary antibodies

Indexed keywords

GLYCOLIPID; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LEPROSTATIC AGENT; MYCOBACTERIUM ANTIGEN;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; COLORIMETRY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; EXPOSURE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LEPROSY; MAJOR CLINICAL STUDY; NONHUMAN; SALIVA LEVEL; TIME;

EID: 34547110530     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702007000200009     Document Type: Article

References (25)

1. Naafs B. Viewpoint: Leprosy after the year 2000. Trop Med Intern Health 2000;5:400-3.
2. Abulafia J., Vignale R.A. Leprosy: accessory immune system as effector of infectious, metabolic and immunologic reactions. Int J Dermatol 2001;40:673-87.
3. Almeida E.C., Martinez A.N., Maniero V.C., et al. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood and nasal secretion of Brazilian household contacts. Mem Inst Oswaldo Cruz 2004;99:509-512.
4. Sinha S., Karman S., Nagarau B., et al. Utility of serodiagnostic tests for leprosy: a study in an endemic population in South India. Lepr Rev 2004;75:266-73.
5. Davey T.F., Rees R.J. The nasal discharge in leprosy: clinical and bacteriological aspects. Lepr Rev 1974;45:121-34.
6. Near K.A., Lefford M.J. Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis. J Clin Microbiol 1992; 30:1105-10.
7. Rojas R.E., Segal-Eiras A. Characterization of circulating immune complexes in leprosy patients and their correlation with specific antibodies against Mycobacterium leprae. Clin Exp Dermatol 1997;22:223-39.
8. Cho S.N., Cellona R.V., Villahermosa L.G., et al. Detection of phenolic glicolypid I of Mycobacterium leprae in sera from leprosy patients before and after start of multidrug therapy. Clin Diagn Lab Immunol 2001;8:138-42.
9. Cho S.-N., Yanagihara, D.L., Hunter S.W., et al. Serological specificity of phenolic glycolipid 1 from Mycobacterhan leprae and use in serodiagnosis of leprosy. Infect Immun 1983;41:1077-83.
10. Brandtzaeg P. Molecular and cellular aspects of the secretory immunoglobulin system. APMIS 1995;103:1-19.
11. Hanson L.A., Dahlman-Hoglund A., Karlsson M., et al. Normal microbial flora of the gut and the immune system. In: Probiotics, Other Nutritional Factors, and Intestinal Microflora, Nestlé Nutrition Workshop Series. (Hanson LA, Yolken H, eds), Philadelphia: Vevey/ Lippincott-Raven Publishers, 1999:217-28.
12. Woznicova V. Immunoglobulin G avidity in infectious diseases. Epidemiol Mikrobiol Immunol 2004;53:4-11.
13. Gutierrez J., Maroto C. Are IgG antibody avidity assays useful in the diagnosis of infectious diseases? A review. Microbios 1996; 87:113-21.
14. Ridley D.S., Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int J Lepr 1966;34:255-73.
15. Jones C.L., Macdonald R.A., Hosking C.S., et al. Estimating the relative avidity of mucosal IgA for antigen. J Immunol Methods 1987; 105:111-17.
16. Holmgren J., Rudin A. Mucosal immunity and bacteria. In: Mucosal Immunology. (Ogra PL et al., eds.), 2nd edn, London: Academic Press Ltd., 1999:685-93.
17. Smith W.C., Smith C.M., Cree I.A., et al. An approach to understanding the transmission of Mycobacterium leprae using molecular and immunological methods: results from the MILEP2 study. Int J Lepr Other Mycobact Dis 2004;72:317-19.
18. Salvi S., Holgate S.T. Could the airway epithelium play an important Tole in mucosal immunoglobulin A production? Clin Exp Alergy 1999; 29:1597-605.
19. Goldblum R.M., Hanson L.A., Brandtzaeg P. The mucosal defense system. In: Immunologic disorders in infants and children. (Stiehm ER, ed.), 4th edn, Philadelphia: WB Saunders Co, 1996:159-97.
20. Marcotte H., Lavoie M.C. Oral microbiology ecology and the role of salivary immunoglobulin A. Microbiol Molec Biol Rev 1998; 62:71-109.
21. Shimon Y., Ng V., Matsumura K., et al. A 21-kDa surface protein of Mycobacterium leprae binds peripheral nerve laminin-2 and mediates Schwann cell invasion. Proc Natl Acad Sci 1999;96:9857-62.
22. Haimanot R.T., Melaku Z. Leprosy. Curr Opin Neurol 2000;13:317-22.
23. Santos A.R., Balassiano V., Oliveira M.L.W., et al. Detection of Mycobacterium leprae DNA by polymerase chain reaction in the blood of individuals, eight years after completion of anti-leprosy therapy. Mem. Inst Oswaldo Cruz 2001;96:1129-33.
24. Tanyuksel M., Guney C., Araz E., et al. Performance of the immunoglobulin G avidity and enzyme immunoassay IgG/IgM screening tests for differentiation of a clinical spectrum of toxoplasmosis. J Microbiol 2004;42:211-5.
25. Andrews J.I., Dickema D.J., Yankowitz J. Prenatal testing for infectious diseases. Clin Lab Med 2003;23:295-315.